Dr. Raza Khan, MD
Claim this profileAultman Health Foundation
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
15 reported clinical trials
29 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
EGFR negative
2Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR negative
Affiliated Hospitals
Clinical Trials Raza Khan, MD is currently running
BRAF-Targeted Therapy
for Colon Cancer
This phase II/III trial compares treatment with encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Giving encorafenib and cetuximab after standard surgery and chemotherapy may be more effective at reducing the chance of cancer recurrence compared to the usual patient observation.
Recruiting1 award Phase 2 & 3
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Raza Khan, MD
Clinical Trial Related1 year of experience running clinical trials · Led 15 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Raza Khan, MD has experience with
- Carboplatin
- Pembrolizumab
- Pemetrexed
- Paclitaxel
- Nab-paclitaxel
- Atezolizumab
Breakdown of trials Raza Khan, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raza Khan, MD specialize in?
Raza Khan, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Raza Khan, MD currently recruiting for clinical trials?
Yes, Raza Khan, MD is currently recruiting for 10 clinical trials in Canton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Raza Khan, MD has studied deeply?
Yes, Raza Khan, MD has studied treatments such as Carboplatin, Pembrolizumab, Pemetrexed.
What is the best way to schedule an appointment with Raza Khan, MD?
Apply for one of the trials that Raza Khan, MD is conducting.
What is the office address of Raza Khan, MD?
The office of Raza Khan, MD is located at: Aultman Health Foundation, Canton, Ohio 44710 United States. This is the address for their practice at the Aultman Health Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.